On August 14, 2024, James Abernathy, Director at National Healthcare Corp (NHC), sold 1,605 shares of the company’s stock. The transaction was filed on the same day through an SEC filing. Following this sale, the insider now owns 33,278 shares of National Healthcare Corp.
National Healthcare Corp operates nursing homes, assisted living, independent living facilities and home care programs. The company’s services focus on medical care and rehabilitation therapy.
Over the past year, the insider has sold a total of 3,155 shares and made no purchases. This latest transaction continues a trend seen at the company where insider sales exceed purchases. Over the past year, there were 4 insider sales and only 2 insider purchases.
National Healthcare Corp.’s stock price was $127 on the day of the sale. The company has a market capitalization of around $1.999 billion. The price-to-earnings ratio is 21.87, which is below the industry median of 23.74, but above the company’s historical median.
The stock is currently considered significantly overvalued with a price-to-GF-Value ratio of 1.62 based on a GF Value of $78.38. The GF Value is calculated by taking into account historical trading multiples, a GuruFocus adjustment factor based on past earnings and growth, and future business development estimates from Morningstar analysts.
This insider sale could be of interest to investors who track ownership changes and evaluate the current valuation of the stock in light of market developments and intrinsic value estimates.
This article created by GuruFocus is intended to provide general insights and does not constitute tailored financial advice. Our commentary is based on historical data and analyst forecasts, uses an unbiased methodology and is not intended to serve as specific investment advice. It does not contain a recommendation to buy or sell any stock and does not take into account any individual investment objectives or financial circumstances. Our goal is to provide long-term, fundamental, data-driven analysis. Note that our analysis may not include the most recent, price-sensitive company announcements or qualitative information. GuruFocus does not hold a position in any stocks mentioned here.
This article first appeared on GuruFocus.
